J&J cited by FDA for another manufacturing facility
July 20, 2010Manufacturing and Production J&J, JJ, manufacturing compliance
Another week, another raft of bad news for Johnson & Johnson’s manufacturing division. With one production facility already shut down …
Excipient problem leads to Coumadin recall
July 20, 2010Manufacturing and Production BMS, manufacturing compliance, recalls
Bristol-Myers Squibb is recalling nearly 150,000 tablets of its anticoagulant product Coumadin distributed across the US because some of them …
Pfizer forced to halt pain drug trials
July 20, 2010Research and Development Pfizer, chronic pain, pain therapeutics, tanezumab
Pfizer has been told by the FDA to suspend trials of its novel injectable biotherapeutic tanezumab for chronic low back …
Manufacturing news in brief
July 20, 2010Manufacturing and Production Apicore, Emergent, Merck & Co, PPS, Tianyin, lilly
A crop of facility announcements from Merck & Co, Emergent, Tianyin, Apicore and PPS offset more job loss news from …
Merck Millipore unveiled as $7bn acquisition completed
July 20, 2010Manufacturing and Production Merck KGaA, Millipore
Germany’s Merck KGaA has completed its $7 billion acquisition of processing equipment specialist Millipore, officially launching the combined Merck Millipore …
TBWAPaling Walters promotes Andy Hayley
July 20, 2010Medical Communications TBWA/Paling Walters, appointment, medical communications
Health communications agency TBWA\Paling Walters has promoted former client services director Andy Hayley to managing director. He will succeed company …
Bayer signs Chinese research deal
July 20, 2010Research and Development Bayer, China, gynaecology
Bayer is partnering with the People’s Liberation Army General Hospital in Beijing on research into women’s healthcare. The People’s Liberation …
Digital Pharma: Byte-sized roundup
July 19, 2010Medical Communications Amgen, Digital Pharma blog, EMA, Sermo, digital doctors, google, psoriasis
This week’s roundup includes EMA’s new look website, a psoriasis patient group’s e-commerce venture, Amgen’s online patient empowerment competition, changes …
NICE’s methods to be put under the spotlight
July 19, 2010Sales and Marketing MRC, NICE, cost-effectiveness
The Medical Research Council has awarded £2.3 million for new research into the academic methods underpinning advice given by NICE …
US approval for Sanofi’s Jevtana
July 19, 2010Sales and Marketing Jevtana, Sanofi-Aventis, chemotherapy, prostate cancer
US regulators have approved Sanofi-Aventis’ chemotherapy agent Jevtana in combination with the steroid prednisone to treat men with prostate cancer. …
Elan expects Zonegran marketing probe to cost it $206m
July 19, 2010Sales and Marketing Elan, Zonegran
Elan Corporation expects to pay $206.3 million to settle a US government investigation into the way it marketed its anti-epileptic …
UCB’s Speers to lead European Medicines Group
July 19, 2010Sales and Marketing European Medicines Group, UCB, appointment, sales and marketing
UCB Pharma’s managing director Matthew Speers has been elected chair of the European Medicines Group, taking over from Nigel Brooksby …
NICE reaffirms positive opinion on Multaq
July 19, 2010Sales and Marketing Multaq, NICE, antiarrhythmic, dronedarone
In its final draft guidance, UK cost-effectiveness body NICE has reaffirmed its previous positive opinion to recommend the limited use …
GSK takes £1.58bn hit from legal disputes
July 16, 2010Sales and Marketing Avandia, GlaxoSmithKline, Paxcil, Seroxat
GlaxoSmithKline is set to pay £1.58 billion to settle three long-standing legal disputes, including litigation costs for its troubled diabetes …
Lonza wins two biologic contracts
July 16, 2010Manufacturing and Production Elusys, Human Genome Sciences, Lonza
Swiss fine chemicals firm Lonza has secured two new contracts for its contract manufacturing division for monoclonal antibodies to treat …
UK pharma needs online pharmacovigilance guidance, says Digital Pioneer
July 16, 2010Medical Communications Code of Practice, Sublime Digital, digital pharma
Pharma companies need more help from UK authorities on the issue of online pharmacovigilance, according to the winner of the …
Eisai collaborates on psychiatric disorder research
July 16, 2010Research and Development Aestus Thereapeutics, Eisai
Eisai is to work with US-based translational medicine company Aestus Therapeutics to develop novel treatments for psychiatric disorders. The companies’ …
Changing business models top pharma concerns
July 16, 2010Sales and Marketing Cegedim, industry, survey
The changing face of pharma business models is the main thing keeping US executives awake at night, according to a …
What might the NHS white paper mean for Pharma commercial models?
July 16, 2010Sales and Marketing Kinapse, NHS, White paper, commercial model, life sciences, pharma
Earlier this year we published a white paper on the new commercial realities and their implications for Life Sciences companies.
Promotions at ScopeMedical
July 16, 2010Medical Communications ScopeMedical, appointment, medical communications
Kent, UK-based medical communications agency ScopeMedical has promoted a number of its team.They are: Sophie Smith (who moves to account …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
